Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Photo: Rolf Vennenbernd/picture alliance via Getty Images
Thermo Fisher is acquiring Qiagen, a company that makes lab equipment and diagnostic tests, for $10.1 billion plus the assumption of $1.4 billion of debt.
Why it matters: This is the largest health care transaction so far in 2020. It's also especially relevant because Qiagen makes a testing kit that detects the new coronavirus strain.